<DOC>
	<DOC>NCT01155427</DOC>
	<brief_summary>The purpose of this study is to support the clinical value of entecavir by assessing the relationship between viral load and histological improvement.</brief_summary>
	<brief_title>Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)</brief_title>
	<detailed_description>Systematic review of prospective clinical trials</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<criteria>Patients with CHB diagnosis and no coinfection with Hep A, Hep C, Hep D, or HIV Age 16 years or older No posttransplant patients RCT, nonrandomized trials, prospective cohort studies, prospectively analyses case series published since 2003 At least one arm of trial must include monotherapy with entecavir, lamivudine, tenofovir, adefovir, or telbivudine Study arms must include at least 10 patients Followup of at least 48 weeks Published results available in English language</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>